FDA Clears Ekso GT Robotic Exoskeleton for Stroke and Spinal Cord Injury
  Patients
From: Medical Design Technology - 04/04/2016

Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced
that it has received clearance from the US Food and Drug Administration (FDA)
to market its Ekso GT robotic exoskeleton for use in the treatment of
individuals with hemiplegia due to stroke, individuals with spinal cord
injuries at levels T4 to L5, and individuals with spinal cord injuries at
levels of T3 to C7 (ASIA D), in accordance with device's labeling. The Ekso
GT is the first exoskeleton cleared by the FDA for use with stroke patients.

Read the entire article and view a video (1:14) at:
http://www.mdtmag.com/news/2016/04/fda-clears-ekso-gt-robotic-exoskeleton-stroke-and-spinal-cord-injury-patients

Links:
Ekso Bionics
http://www.eksobionics.com

Ekso GT Exoskeleton Cleared by FDA (with video 1:14)
http://www.roboticstrends.com/article/ekso_gt_exoskeleton_cleared_by_fda